Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
3.840
-0.060 (-1.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.06 million as of December 20, 2024. Its market cap has decreased by -46.06% in one year.
Market Cap
2.06M
Enterprise Value
-3.44M
1-Year Change
-46.06%
Ranking
Category
Stock Price
$3.84
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.06M, a decrease of -96.94%. That is a compound annual growth rate of -67.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.06M | 36.61% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shuttle Pharmaceuticals Holdings | 2.32M |
| Salarius Pharmaceuticals | 2.28M |
| Aptevo Therapeutics | 2.27M |
| Dermata Therapeutics | 2.24M |
| NanoVibronix | 2.21M |
| Cyclacel Pharmaceuticals | 2.08M |
| IMAC Holdings | 2.08M |
| Akanda | 2.01M |